Research and Development

Showing 15 posts of 9573 posts found.

Obama ends stem cell funding ban

March 10, 2009 Research and Development US, stem cell

President Obama has lifted the US ban on federal funding for new stem cell research, signalling another marked departure in …

Are biosimilars delivering the goods in the EU?

March 10, 2009 Manufacturing and Production, Research and Development biosimilars

In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …

UK’s Stem Cell Sciences acquired by US company

March 5, 2009 Research and Development Stem cells

US company StemCells Inc is to expand its capabilities in the field with the purchase of UK based Stem Cell …

NICE rejects Tyverb despite price offer

March 5, 2009 Research and Development NICE, Tyverb

NICE has rejected GSK's breast cancer drug Tyverb, despite an offer from the company to cut the cost of treatment. …

Obama makes ‘downpayment’ on US healthcare reform

March 5, 2009 Research and Development US, healthcare

President Barack Obama has reiterated his aim of bringing universal healthcare to the US and has put a $76.8 billion …

Symbicort gains COPD indication

March 4, 2009 Research and Development Symbicort

AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …

First-in-class cancer treatment Vidaza launched

March 3, 2009 Research and Development Vidaza

Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …

Chinese move marks ‘globalisation’ of Bayer Schering R&D

March 2, 2009 Research and Development Asia, Bayer, China

Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …

Novartis vaccine recalled after contamination scare

February 26, 2009 Manufacturing and Production, Research and Development Vaccine

Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …

Time running out for pharma sales and marketing

February 26, 2009 Research and Development, Sales and Marketing pwC, strategy

The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …

Europe approves Lilly’s Plavix rival

February 25, 2009 Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

NovaBiotics: a rising star for 2009

February 24, 2009 Research and Development NovaBiotics

Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …
The Gateway to Local Adoption Series

Latest content